ArticleOncoimmunology

A single centre phase II trial to assess the immunological activity of TroVax® plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma - the SKOPOS trial.

Jason F Lester et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.